Fundz

Nouscom Raises €67.5 Million ($72 Million) In Oversubscribed Series C Financing Round

PRIVATENov 14, 2023

Amount Raised

€67.5 Million

Round Type

Series C

BaselBiotechnologyHealth CareTherapeutics

Description

Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today announced the completion of its oversubscribed Series C equity financing raising €67.5 million ($72 million) from a syndicate of renowned international healthcare investors.

Quick answer

Nouscom raised €67.5 Million in a Series C round, dated November 14, 2023. Nouscom is based in Basel, Basel City, Switzerland.

How much did Nouscom raise?
Nouscom raised €67.5 Million in a Series C round on November 14, 2023.
What does Nouscom do?
Nouscom is a private clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with demonstrated high immunogenicity in patients.
Where is Nouscom based and how big is it?
Nouscom is based in Basel, Basel City, Switzerland. Fundz records about 11 employees.
Who are the decision-makers at Nouscom?
Fundz holds 1 contact at Nouscom. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Nouscom that raised within 45 days of this round, from Fundz verified event records.

  • Alpha Cognition raised $1.8M (Seed) on December 22, 2023.
  • Cadenza Bio raised an undisclosed amount (Funding Round) on December 20, 2023.
  • Sudo Biosciences raised $116M (Series B) on December 20, 2023.
  • Sudo Biosciences raised $53M on December 15, 2023.
  • Cadenza Bio raised $2.4M (Seed) on December 14, 2023.
  • Bicara Therapeutics raised $165M (Series C) on December 12, 2023.

Who to call at Nouscom, and when

A new round usually means Nouscom is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nouscom raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nouscom, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nouscom. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nouscom

Location

Basel, Basel City, Switzerland

About

Nouscom is a private clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with demonstrated high immunogenicity in patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nouscom raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Nouscom's next move

See what Strategic adds

Nouscom raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.